Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02500628 : Heart Rate Variability in Response to Metformin Challenge
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

EITHER chronic neurogenic pain meeting ACR criteria for fibromyalgia or previous/current
exposure to antipsychotic medications

Exclusion Criteria:

- recent infection,

- renal failure,

- pre-existing cardiac disease,

- COPD,

- inability to participate in informed consent,

- lack of transport to return home from study site,

- severe fasting intolerance or hypoglycemia,

- history of stroke-alike episode,

- uncontrolled migraine or cyclic vomiting,

- diabetes on insulin or sulfonylurea,

- non-English speaker,

- medications with strong effects on baseline heart rate variability
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02500628      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740